Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD

NCT07425210 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Lung Disease (COLD)

Interventions

DRUG: HSK39004 Dry Powder Inhaler -0.75mg BID

Sponsor

Haisco Pharmaceutical Group Co., Ltd.